首页 | 本学科首页   官方微博 | 高级检索  
     检索      

Boron-based Drug Design for Cancer Therapy
作者单位:Department of Chemistry Gakushuin University,Department of Chemistry,Gakushuin University,Department of Chemistry,Gakushuin University,Department of Chemistry,Gakushuin University,Tokyo 171-8588,Japan,Tokyo 171-8588,Japan,Tokyo 171-8588,Japan,Tokyo 171-8588,Japan
摘    要:1 Results Selective inhibition of protein tyrosine kinases is gaining importance as an effective therapeutic approach for the treatment of a wide range of human cancers.The epidermal growth factor receptor (EGFR) protein tyrosine kinase is one of the important kinases that play a fundamental role in cell growth signal pathways.We focused on the 4-anilinoquinazoline framework,which is observed in both compounds as a common structure.A boron atom has a vacant orbital and interconverts with ease between the neutral sp2 and the anionic sp3 hybridization states.This generates a new stable interaction between the boron atom and a donor molecule through a covalent bond.Therefore,it is expected that the boron atoms introduced into quinazoline framework would interact with a target protein not only through hydrogen bonds but also through covalent bonds,which would produce potent biological activity We introduced a boronic acid moiety into R1 and R3 groups as shown in Scheme 1.

本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号